{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:45:05Z","timestamp":1790757905226,"version":"4.1.0"},"reference-count":47,"publisher":"Japan Neurosurgical Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2019]]},"DOI":"10.2176\/nmc.st.2019-0034","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T18:03:19Z","timestamp":1557511399000},"page":"257-263","source":"Crossref","is-referenced-by-count":18,"title":["Macrophage Imaging of Intracranial Aneurysms"],"prefix":"10.2176","volume":"59","author":[{"given":"Kampei","family":"SHIMIZU","sequence":"first","affiliation":[{"name":"Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center"},{"name":"Department of Neurosurgery, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"KUSHAMAE","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center"},{"name":"Department of Neurosurgery, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"AOKI","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Vlak MH, Algra A, Brandenburg R, Rinkel GJ: Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. <i>Lancet Neurol<\/i> 10: 626\u2013636, 2011","DOI":"10.1016\/S1474-4422(11)70109-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Aoki T, Nozaki K: Preemptive medicine for cerebral aneurysms. <i>Neurol Med Chir<\/i> (<i>Tokyo<\/i>) 56: 552\u2013568, 2016","DOI":"10.2176\/nmc.st.2016-0063"},{"key":"3","unstructured":"3) Greving JP, Wermer MJ, Brown RD, et al.: Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. <i>Lancet Neurol<\/i> 13: 59\u201366, 2014"},{"key":"4","unstructured":"4) Kotowski M, Naggara O, Darsaut TE, et al.: Safety and occlusion rates of surgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis of the literature from 1990 to 2011. <i>J Neurol Neurosurg Psychiatry<\/i> 84: 42\u201348, 2013"},{"key":"5","unstructured":"5) Ishibashi T, Murayama Y, Urashima M, et al.: Unruptured intracranial aneurysms: incidence of rupture and risk factors. <i>Stroke<\/i> 40: 313\u2013316, 2009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Juvela S, Porras M, Poussa K: Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. <i>J Neurosurg<\/i> 93: 379\u2013387, 2000","DOI":"10.3171\/jns.2000.93.3.0379"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) UCAS Japan Investigators, Morita A, Kirino T, Hashi K, et al.: The natural course of unruptured cerebral aneurysms in a Japanese cohort. <i>N Engl J Med<\/i> 366: 2474\u20132482, 2012","DOI":"10.1056\/NEJMoa1113260"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sonobe M, Yamazaki T, Yonekura M, Kikuchi H: Small unruptured intracranial aneurysm verification study: SUAVe study, Japan. <i>Stroke<\/i> 41: 1969\u20131977, 2010","DOI":"10.1161\/STROKEAHA.110.585059"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wermer MJ, van der Schaaf IC, Velthuis BK, Majoie CB, Albrecht KW, Rinkel GJ: Yield of short-term follow-up CT\/MR angiography for small aneurysms detected at screening. <i>Stroke<\/i> 37: 414\u2013418, 2006","DOI":"10.1161\/01.STR.0000199077.06390.35"},{"key":"10","unstructured":"10) Wiebers DO, Whisnant JP, Huston J, et al.: Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. <i>Lancet<\/i> 362: 103\u2013110, 2003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N: Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. <i>Stroke<\/i> 40: 942\u2013951, 2009","DOI":"10.1161\/STROKEAHA.108.532556"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N: Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. <i>Stroke<\/i> 38: 162\u2013169, 2007","DOI":"10.1161\/01.STR.0000252129.18605.c8"},{"key":"13","unstructured":"14) Aoki T, Koseki H, Miyata H, Abekura Y, Shimizu K: [Intracranial aneurysm as an inflammation-related disease]. <i>No Shinkei Geka<\/i> 46: 275\u2013294, 2018 (Japaneae)"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Shimizu K, Kushamae M, Mizutani T, Aoki T: Intracranial aneurysm as a macrophage-mediated inflammatory disease. <i>Neurol Med Chir<\/i> (<i>Tokyo<\/i>) 59: 126\u2013132, 2019","DOI":"10.2176\/nmc.st.2018-0326"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Kanematsu Y, Kanematsu M, Kurihara C, et al.: Critical roles of macrophages in the formation of intracranial aneurysm. <i>Stroke<\/i> 42: 173\u2013178, 2011","DOI":"10.1161\/STROKEAHA.110.590976"},{"key":"16","unstructured":"17) Aoki T, Saito M, Koseki H, et al.: Macrophage imaging of cerebral aneurysms with ferumoxytol: an exploratory study in an animal model and in patients. <i>J Stroke Cerebrovasc Dis<\/i> 26: 2055\u20132064, 2017"},{"key":"17","unstructured":"18) Hasan D, Chalouhi N, Jabbour P, et al.: Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study. <i>Stroke<\/i> 43: 3258\u20133265, 2012"},{"key":"18","unstructured":"19) Hasan DM, Chalouhi N, Jabbour P, et al.: Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results. <i>J Am Heart Assoc<\/i> 2: e000019, 2013"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Alam SR, Stirrat C, Richards J, et al.: Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide. <i>J Cardiovasc Magn Reson<\/i> 17: 83, 2015","DOI":"10.1186\/s12968-015-0183-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) McConnell HL, Schwartz DL, Richardson BE, Woltjer RL, Muldoon LL, Neuwelt EA: Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific. <i>Nanomedicine<\/i> 12: 1535\u20131542, 2016","DOI":"10.1016\/j.nano.2016.03.009"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Kirschbaum K, Sonner JK, Zeller MW, et al.: In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. <i>Proc Natl Acad Sci USA<\/i> 113: 13227\u201313232, 2016","DOI":"10.1073\/pnas.1609397113"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23) Sadat U, Usman A, Gillard JH: Imaging pathobiology of carotid atherosclerosis with ultrasmall superparamagnetic particles of iron oxide: an update. <i>Curr Opin Cardiol<\/i> 32: 437\u2013440, 2017","DOI":"10.1097\/HCO.0000000000000413"},{"key":"23","unstructured":"24) Iv M, Samghabadi P, Holdsworth S, et al.: Quantification of macrophages in high-grade gliomas by using ferumoxytol-enhanced MRI: a pilot study. <i>Radiology<\/i> 290: 198\u2013206, 2019"},{"key":"24","unstructured":"25) Fr\u00f6sen J, Piippo A, Paetau A, et al.: Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. <i>Stroke<\/i> 35: 2287\u20132293, 2004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26) Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R: Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. <i>Stroke<\/i> 30: 1396\u20131401, 1999","DOI":"10.1161\/01.STR.30.7.1396"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27) Aoki T, Nishimura M: The development and the use of experimental animal models to study the underlying mechanisms of CA formation. <i>J Biomed Biotechnol<\/i> 2011: 535921, 2011","DOI":"10.1155\/2011\/535921"},{"key":"27","unstructured":"28) Hashimoto N, Handa H, Hazama F: Experimentally induced cerebral aneurysms in rats. <i>Surg Neurol<\/i> 10: 3\u20138, 1978"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29) Backes D, Rinkel GJ, Laban KG, Algra A, Vergouwen MD: Patient- and aneurysm-specific risk factors for intracranial aneurysm growth: a systematic review and meta-analysis. <i>Stroke<\/i> 47: 951\u2013957, 2016","DOI":"10.1161\/STROKEAHA.115.012162"},{"key":"29","unstructured":"30) Murray PJ, Allen JE, Biswas SK, et al.: Macrophage activation and polarization: nomenclature and experimental guidelines. <i>Immunity<\/i> 41: 14\u201320, 2014"},{"key":"30","unstructured":"31) Hasan D, Chalouhi N, Jabbour P, Hashimoto T: Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results. <i>J Neuroinflammation<\/i> 9: 222, 2012"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32) Aoki T, Kataoka H, Shimamura M, et al.: NF-kappaB is a key mediator of cerebral aneurysm formation. <i>Circulation<\/i> 116: 2830\u20132840, 2007","DOI":"10.1161\/CIRCULATIONAHA.107.728303"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33) Aoki T, Fukuda M, Nishimura M, Nozaki K, Narumiya S: Critical role of TNF-alpha-TNFR1 signaling in intracranial aneurysm formation. <i>Acta Neuropathol Commun<\/i> 2: 34, 2014","DOI":"10.1186\/2051-5960-2-34"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34) Starke RM, Chalouhi N, Jabbour PM, et al.: Critical role of TNF-<i>\u03b1<\/i> in cerebral aneurysm formation and progression to rupture. <i>J Neuroinflammation<\/i> 11: 77, 2014","DOI":"10.1186\/1742-2094-11-77"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35) Moriwaki T, Takagi Y, Sadamasa N, Aoki T, Nozaki K, Hashimoto N: Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. <i>Stroke<\/i> 37: 900\u2013905, 2006","DOI":"10.1161\/01.STR.0000204028.39783.d9"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36) Aoki T, Nishimura M, Matsuoka T, et al.: PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-\u03baB. <i>Br J Pharmacol<\/i> 163: 1237\u20131249, 2011","DOI":"10.1111\/j.1476-5381.2011.01358.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37) Fukuda S, Hashimoto N, Naritomi H, et al.: Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. <i>Circulation<\/i> 101: 2532\u20132538, 2000","DOI":"10.1161\/01.CIR.101.21.2532"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38) Nuki Y, Tsou TL, Kurihara C, Kanematsu M, Kanematsu Y, Hashimoto T: Elastase-induced intracranial aneurysms in hypertensive mice. <i>Hypertension<\/i> 54: 1337\u20131344, 2009","DOI":"10.1161\/HYPERTENSIONAHA.109.138297"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39) Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N: Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms. <i>Stroke<\/i> 39: 2603\u20132610, 2008","DOI":"10.1161\/STROKEAHA.107.513648"},{"key":"39","unstructured":"40) Hasan DM, Mahaney KB, Magnotta VA, et al.: Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study. <i>Arterioscler Thromb Vasc Biol<\/i> 32: 1032\u20131038, 2012"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41) D\u00f3sa E, Tuladhar S, Muldoon LL, Hamilton BE, Rooney WD, Neuwelt EA: MRI using ferumoxytol improves the visualization of central nervous system vascular malformations. <i>Stroke<\/i> 42: 1581\u20131588, 2011","DOI":"10.1161\/STROKEAHA.110.607994"},{"key":"41","unstructured":"42) Weinstein JS, Varallyay CG, Dosa E, et al.: Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. <i>J Cereb Blood Flow Metab<\/i> 30: 15\u201335, 2010"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43) Yang M, Christoforidis GA, Figueredo T, Heverhagen JT, Abduljalil A, Knopp MV: Dosage determination of ultrasmall particles of iron oxide for the delineation of microvasculature in the Wistar rat brain. <i>Invest Radiol<\/i> 40: 655\u2013660, 2005","DOI":"10.1097\/01.rli.0000178432.22377.6c"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44) Edjlali M, Gu\u00e9don A, Ben Hassen W, et al.: Circumferential thick enhancement at vessel wall MRI has high specificity for intracranial aneurysm instability. <i>Radiology<\/i> 289: 181\u2013187, 2018","DOI":"10.1148\/radiol.2018172879"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45) Edjlali M, Gentric JC, R\u00e9gent-Rodriguez C, et al.: Does aneurysmal wall enhancement on vessel wall MRI help to distinguish stable from unstable intracranial aneurysms? <i>Stroke<\/i> 45: 3704\u20133706, 2014","DOI":"10.1161\/STROKEAHA.114.006626"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46) Omodaka S, Endo H, Niizuma K, et al.: Circumferential wall enhancement in evolving intracranial aneurysms on magnetic resonance vessel wall imaging. <i>J Neurosurg<\/i> 1\u20137, 2018","DOI":"10.3171\/2018.5.JNS18322"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47) Shimonaga K, Matsushige T, Ishii D, et al.: Clinicopathological insights from vessel wall imaging of unruptured intracranial aneurysms. <i>Stroke<\/i> 49: 2516\u20132519, 2018","DOI":"10.1161\/STROKEAHA.118.021819"},{"key":"47","unstructured":"48) Larsen N, von der Brelie C, Trick D, et al.: Vessel wall enhancement in unruptured intracranial aneurysms: an indicator for higher risk of rupture? high-resolution MR imaging and correlated histologic findings. <i>AJNR Am J Neuroradiol<\/i> 39: 1617\u20131621, 2018"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/59\/7\/59_st.2019-0034\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T23:29:39Z","timestamp":1563578979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/59\/7\/59_st.2019-0034\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2176\/nmc.st.2019-0034","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}